Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

 		Myeloid Leukemia, Philadelphia Positive Phase1, Phase2 United States
Greece
Thailand
China
France
Hungary
Turkey
Germany
Italy
Russian Federation
Japan
Korea, Republic of
Netherlands
Poland
View All

The Gilenya Pregnancy Registry

 		Multiple Sclerosis Denmark
Portugal
Netherlands
Greece
Argentina
Lebanon
Germany
Colombia
Australia
Belgium
France
Romania
Hungary
United States
Italy
Ireland
Austria
Saudi Arabia
Israel
Poland
Mexico
Russian Federation
Cyprus
Czechia
Brazil
Canada
Finland
View All

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

 		Neuroblastoma Phase1, Phase2 United States
Spain
Germany
Italy
Australia
Singapore
France
View All

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

 		Chronic Myeloid Leukemia France

A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy

 		Achilles Tendinopathy Phase2 United States
Germany
France
United Kingdom
View All

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

 		Breast Cancer Phase1 Spain
France
Germany
Poland
Portugal
View All

A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.

 		Small Cell Lung Carcinoma Phase1 United States

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

 		MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Phase1 United States
Spain
France
Belgium
Germany
Japan
Italy
Norway
Korea, Republic of
Singapore
Sweden
Taiwan
Israel
View All

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

 		Chronic Spontaneous Urticaria Phase3 United States
Argentina

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

 		Chronic Inducible Urticaria Phase3 United States
Argentina
Australia
China
Canada
View All